S
Soyoung Kim
Researcher at Medical College of Wisconsin
Publications - 49
Citations - 596
Soyoung Kim is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 11, co-authored 33 publications receiving 283 citations. Previous affiliations of Soyoung Kim include University of North Carolina at Chapel Hill & Center for International Blood and Marrow Transplant Research.
Papers
More filters
Journal ArticleDOI
Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort
Johanna W. Lampe,Ying Huang,Marian L. Neuhouser,Lesley F. Tinker,Xiaoling Song,Dale A. Schoeller,Soyoung Kim,Daniel Raftery,Chongzhi Di,Cheng Zheng,Yvonne Schwarz,Linda Van Horn,Cynthia A. Thomson,Yasmin Mossavar-Rahmani,Shirley A.A. Beresford,Ross L. Prentice +15 more
TL;DR: Serum concentration biomarkers of several vitamins and carotenoids performed similarly to established energy and protein urinary recovery biomarkers in representing nutrient intake variation in a feeding study, and thus are likely suitable for application in this population of postmenopausal women.
Journal ArticleDOI
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis
Scott R. Goldsmith,Muhammad Bilal Abid,Jeffery J. Auletta,Asad Bashey,Amer Beitinjaneh,Paul Castillo,Roy F. Chemaly,Min Chen,Stefan O. Ciurea,Christopher E. Dandoy,Miguel Angel Diaz,Ephraim J. Fuchs,Siddhartha Ganguly,Christopher G. Kanakry,Jennifer A. Kanakry,Soyoung Kim,Krishna V. Komanduri,Maxwell M. Krem,Hillard M. Lazarus,Hongtao Liu,Per Ljungman,Per Ljungman,Richard Masiarz,Carolyn Mulroney,Sunita Nathan,Taiga Nishihori,Kristin Page,Miguel-Angel Perales,Randy Taplitz,Rizwan Romee,Marcie L. Riches,Marcie L. Riches +31 more
TL;DR: The role of allograft source and posttransplant cyclophosphamide (PTCy) in CMV infection is unclear as mentioned in this paper, and the effect of graft source and PTCy on incidence of CMV infections was analyzed.
Journal ArticleDOI
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
Celalettin Ustun,Jo Anne H. Young,Genovefa A. Papanicolaou,Soyoung Kim,Kwang Woo Ahn,Min Chen,Hisham Abdel-Azim,Mahmoud Aljurf,Amer Beitinjaneh,Valerie I. Brown,Jan Cerny,Saurabh Chhabra,Mohamed A. Kharfan-Dabaja,Parastoo B. Dahi,Andrew Daly,Christopher E. Dandoy,Christopher C. Dvorak,Cesar O. Freytes,Shahrukh K. Hashmi,Shahrukh K. Hashmi,Hillard M. Lazarus,Per Ljungman,Taiga Nishihori,Kristin Page,Sai Ravi Pingali,Ayman Saad,Bipin N. Savani,Daniel J. Weisdorf,Kirsten M. Williams,Baldeep Wirk,Jeffery J. Auletta,Caroline A. Lindemans,Krishna V. Komanduri,Marcie L. Riches +33 more
TL;DR: Patients with BSI-VEP were more likely to receive a myeloablative conditioning (MAC) regimen with total body irradiation (TBI), and NRM was significantly higher in patients with any BSI than in patients without BSI, while OS was significantly lower.
Journal ArticleDOI
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Regina M. Myers,Brian T. Hill,Bronwen E. Shaw,Soyoung Kim,Heather R. Millard,Minoo Battiwalla,Navneet S. Majhail,David Buchbinder,Hillard M. Lazarus,Bipin N. Savani,Mary E. D. Flowers,Anita D'Souza,Matthew J. Ehrhardt,Amelia Langston,Jean A. Yared,Robert J. Hayashi,Andrew Daly,Richard F. Olsson,Yoshihiro Inamoto,Adriana K. Malone,Zachariah DeFilipp,Steven P. Margossian,Anne B. Warwick,Samantha Jaglowski,Amer Beitinjaneh,Henry C. Fung,Kimberly A. Kasow,David I. Marks,Jana Reynolds,Keith Stockerl-Goldstein,Baldeep Wirk,William A. Wood,Mehdi Hamadani,Prakash Satwani +33 more
TL;DR: Autologous hematopoietic cell transplantation is a standard therapy for relapsed classic Hodgkin lymphoma and diffuse large B‐cell lymphoma; however, long‐term outcomes are not well described.
Journal ArticleDOI
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
Christopher E. Dandoy,Soyoung Kim,Soyoung Kim,Min Chen,Kwang Woo Ahn,Kwang Woo Ahn,Monica I. Ardura,Valerie I. Brown,Saurabh Chhabra,Saurabh Chhabra,Miguel Angel Diaz,Christopher C. Dvorak,Nosha Farhadfar,Aron Flagg,S Ganguly,Gregory A. Hale,Shahrukh K. Hashmi,Peiman Hematti,Rodrigo Martino,Taiga Nishihori,Roomi Nusrat,Richard F. Olsson,Richard F. Olsson,Seth J. Rotz,Anthony D. Sung,Miguel-Angel Perales,Caroline A. Lindemans,Krishna V. Komanduri,Marcie L. Riches +28 more
TL;DR: Mucosal barrier injury–laboratory confirmed bloodstream infections are associated with significant morbidity and mortality and, by extension, increased use of health care resources.